Kingfisher PLC has announced the purchase of 25,000 ordinary shares on 23 February 2026 for cancellation as part of its £300 million share repurchase programme. These shares were acquired from Goldman Sachs International at a volume-weighted average price of £3.5794, with the highest price paid being £3.5960 and the lowest £3.5650. This transaction brings the total shares purchased for cancellation under the fifth tranche of the programme to 18,988,200.
Kingfisher plc, ISIN: GB0033195214 (the "Company", "Kingfisher") announces that on 23 February 2026 it purchased for cancellation the following number of ordinary shares of 15 5/7 pence each from Goldman Sachs International ("GSI") as part of its £300 million share repurchase programme announced on 25 March 2025 (the "Programme"). All shares were purchased by Kingfisher from GSI as an "on-exchange" transaction subject to the rules of the London Stock Exchange.
Date of Purchase:
23 February 2026
Total number of shares purchased:
25,000
Volume Weighted Average price paid per share:
£3.5794
Highest price paid per share:
£3.5960
Lowest price paid per share:
£3.5650
To date, Kingfisher has purchased 18,988,200 ordinary shares in aggregate for cancellation from GSI in connection with the fifth tranche of the Programme. Kingfisher also previously purchased 17,932,871 ordinary shares in aggregate for cancellation from GSI,18,118,306 ordinary shares in aggregate for cancellation from BNP Paribas SA, 24,713,988 ordinary shares in aggregate for cancellation from GSI and 16,095,884 ordinary shares in aggregate for cancellation from Morgan Stanley & Co. International Plc in connection with its execution of the first, second, third and fourth tranches, respectively, of the Programme.
A schedule of individual trades carried out by GSI as principal in connection with the above purchases is set out below.
Schedule of Purchases - Aggregate Information
Trading Venue
Number of Shares
Volume Weighted Average Price paid per share
XLON
25,000
£3.5794
CHIX
0
£0.0000
BATE
0
£0.0000
TRQX
0
£0.0000
AQXE
0
£0.0000
Schedule of Purchases - Individual Transactions
Price GBP
Time of each trade on 23 Feb 2026 (GMT)
Trading Venue
Number of Shares
Transaction Reference Number
3.5690
08:33:21
XLON
951
1395375357303352
3.5690
08:35:50
XLON
1,500
1395375357303555
3.5860
09:02:30
XLON
960
1395375357305470
3.5750
09:32:03
XLON
1,066
1395375357307989
3.5720
09:59:45
XLON
1,041
1395375357310439
3.5650
10:26:11
XLON
1,018
1395375357312251
3.5670
10:58:03
XLON
952
1395375357314709
3.5930
11:53:39
XLON
975
1395375357317834
3.5910
11:56:03
XLON
1,102
1395375357317992
3.5860
12:25:24
XLON
944
1395375357319553
3.5880
13:23:00
XLON
1,578
1395375357322534
3.5960
13:47:22
XLON
1,157
1395375357323849
3.5950
14:11:02
XLON
1,061
1395375357325752
3.5880
14:30:13
XLON
962
1395375357327529
3.5820
14:40:00
XLON
996
1395375357331120
3.5750
14:51:55
XLON
1,159
1395375357335304
3.5690
15:02:30
XLON
1,037
1395375357338461
3.5730
15:22:53
XLON
1,182
1395375357343222
3.5710
15:29:28
XLON
947
1395375357344386
3.5710
15:47:34
XLON
954
1395375357347618
3.5830
16:01:06
XLON
394
1395375357350406
3.5830
16:01:23
XLON
547
1395375357350525
3.5770
16:12:19
XLON
941
1395375357353655
3.5800
16:21:20
XLON
982
1395375357356909
3.5840
16:26:01
XLON
594
1395375357358563
Contacts:
Tel:
Email:
Group Company Secretariat
+44 (0) 20 7372 8008
secretariat@kingfisher.com
Investor Relations
+44 (0) 20 7644 1082
investorenquiries@kingfisher.com
Treasury
+44 (0) 20 7372 8008
treasury@kingfisher.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.
